ES482155A1 - Un procedimiento para la preparacion de derivados de feneta-nolamina. - Google Patents

Un procedimiento para la preparacion de derivados de feneta-nolamina.

Info

Publication number
ES482155A1
ES482155A1 ES482155A ES482155A ES482155A1 ES 482155 A1 ES482155 A1 ES 482155A1 ES 482155 A ES482155 A ES 482155A ES 482155 A ES482155 A ES 482155A ES 482155 A1 ES482155 A1 ES 482155A1
Authority
ES
Spain
Prior art keywords
epinephrine
preparation
derivatives
phenethanolamines
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES482155A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES482155A1 publication Critical patent/ES482155A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/06Preparation of carboxylic acid nitriles from N-formylated amino compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/38Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/487Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/04Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)

Abstract

Procedimientos para la preparación de nuevos derivados de fenetanolamina, útiles para controlar el peso de los mamíferos. Se han realizado extensas investigaciones en el campo de los derivados de beta-feniletilamina, como las catecolaminas. Por ejemplo, se ha estudiado mucho la catecolamina natural, epinefrina. La epinefrina es un potente fármaco simpatomimético y un intenso estimulante cardiaco. Sin embargo, el uso de la epinefrina es limitado debido a sus efectos secundarios indeseables entre los que se encuentran temor, ansiedad, temblores, tensión nerviosa, dolores de cabeza con latidos, mayor presión sanguínea, vértigos, dificultades respiratorias y palpitaciones así como debido a su corta duración de acción.
ES482155A 1978-07-03 1979-07-03 Un procedimiento para la preparacion de derivados de feneta-nolamina. Expired ES482155A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92167078A 1978-07-03 1978-07-03

Publications (1)

Publication Number Publication Date
ES482155A1 true ES482155A1 (es) 1980-08-16

Family

ID=25445792

Family Applications (4)

Application Number Title Priority Date Filing Date
ES482155A Expired ES482155A1 (es) 1978-07-03 1979-07-03 Un procedimiento para la preparacion de derivados de feneta-nolamina.
ES482156A Expired ES482156A1 (es) 1978-07-03 1979-07-03 Un procedimiento para la preparacion de nuevos derivados de-fenetanolamina.
ES490215A Expired ES8104190A1 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de derivados de feneta-nolamina
ES490214A Expired ES8104189A1 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de derivados de feneta-nolamina

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES482156A Expired ES482156A1 (es) 1978-07-03 1979-07-03 Un procedimiento para la preparacion de nuevos derivados de-fenetanolamina.
ES490215A Expired ES8104190A1 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de derivados de feneta-nolamina
ES490214A Expired ES8104189A1 (es) 1978-07-03 1980-04-01 Un procedimiento para la preparacion de derivados de feneta-nolamina

Country Status (31)

Country Link
EP (3) EP0007204B1 (es)
JP (2) JPS559097A (es)
KR (1) KR880002310B1 (es)
AR (4) AR229080A1 (es)
AT (2) AT367025B (es)
AU (2) AU523720B2 (es)
BE (2) BE877393A (es)
BG (4) BG31375A3 (es)
CA (2) CA1145767A (es)
CH (2) CH642618A5 (es)
CS (4) CS208662B2 (es)
DD (2) DD144762A5 (es)
DE (2) DE2964604D1 (es)
DK (2) DK268779A (es)
EG (1) EG14238A (es)
ES (4) ES482155A1 (es)
FI (2) FI792082A7 (es)
FR (3) FR2430411A1 (es)
GB (3) GB2028799B (es)
GR (2) GR74524B (es)
HU (2) HU179172B (es)
IE (2) IE48586B1 (es)
IL (2) IL57672A (es)
LU (2) LU81458A1 (es)
NZ (2) NZ190861A (es)
PH (2) PH14522A (es)
PL (4) PL117996B1 (es)
PT (2) PT69839A (es)
RO (4) RO83051B (es)
SU (4) SU965350A3 (es)
ZA (2) ZA793296B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006735B1 (en) * 1978-06-28 1983-06-15 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
DE3061693D1 (en) * 1979-10-25 1983-02-24 Beecham Group Plc Secondary amines, their preparation and use in pharmaceutical compositions
DE3070865D1 (en) * 1979-11-15 1985-08-14 Beecham Group Plc Secondary ethanol amines, their preparation and their use in pharmaceutical compositions
DE3161165D1 (en) * 1980-05-08 1983-11-17 Beecham Group Plc Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions
EP0066351B1 (en) * 1981-03-06 1985-06-26 Beecham Group Plc Arylethanol amine derivatives, their preparation and use in pharmaceutical compositions
DE3260490D1 (en) * 1981-03-31 1984-09-06 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
EP0070133B1 (en) * 1981-07-11 1986-05-14 Beecham Group Plc Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application
EP0089154A3 (en) * 1982-03-12 1984-08-08 Beecham Group Plc Ethanolamine derivatives, their preparation and use in pharmaceutical compositions
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
JPS5980640A (ja) * 1982-09-27 1984-05-10 イーライ・リリー・アンド・カンパニー 2−ヒドロキシ−2−フエニルエチルアミン類の製造方法
DK171627B1 (da) * 1983-01-31 1997-03-03 Lilly Co Eli Anvendelse af beta-phenethanolamin og farmaceutiskacceptable salte deraf samt dyrefoderpræblanding med indhold deraf
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
US4602044A (en) * 1983-12-19 1986-07-22 Eli Lilly And Company β-phenethanolamine antiobesity agents
JPS60158153A (ja) * 1984-01-12 1985-08-19 イーライ・リリー・アンド・カンパニー 変力剤
ES8800842A1 (es) * 1985-03-01 1987-12-01 Beecham Group Plc Un procedimiento para preparar una formulacion veterinariamente aceptable de ariletanolaminas promotora del crecimiento.
GB8505284D0 (en) * 1985-03-01 1985-04-03 Beecham Group Plc Growth promoters
IT1204416B (it) * 1986-06-27 1989-03-01 Midy Spa Medicamenti a base di analoghi di feniletanolammine per il trattamento di disturbi gastro-intestinali ed uterini
JP2837408B2 (ja) * 1987-05-30 1998-12-16 鐘紡株式会社 アクリル系繊維の処理方法
US5135955A (en) * 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
FI892341A7 (fi) * 1988-06-10 1989-12-11 Hoffmann La Roche Propanoliamiinijohdannaisia
CA2023954C (en) * 1989-10-17 1999-05-04 Hiroyuki Nohira Process for the optical resolution of 2-(3-benzoyl) phenylpropionic acid
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
RU2147574C1 (ru) * 1991-08-23 2000-04-20 Эн-Пи-Эс Фармасьютикалз, Инк. Арилалкиламины, композиции, способы лечения и диагностики, способы идентификации соединения
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6211244B1 (en) 1994-10-21 2001-04-03 Nps Pharmaceuticals, Inc. Calcium receptor-active compounds
EP0907631B1 (en) 1996-05-01 2003-06-18 Nps Pharmaceuticals, Inc. Inorganic ion receptor-active compounds
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL56308C (es) * 1941-03-15
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
GB1301134A (en) 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES
BE788850A (fr) * 1972-09-15 1973-03-15 Hoffmann La Roche Derives d'acide benzoique
US4000192A (en) * 1973-05-07 1976-12-28 Allen & Hanburys Limited Pharmacologically active compounds
IE39247B1 (en) * 1973-05-07 1978-08-30 Allen & Hanburys Ltd Substituted benzamides
NZ190854A (en) * 1978-06-28 1984-10-19 Beecham Group Ltd 2-hydroxy-2-phenyl ethylamine derivatives;pharmaceutical compositions
CA1145766A (en) * 1978-07-03 1983-05-03 Jack Mills Optically active phenethanolamines and method for increasing cardiac contractility

Also Published As

Publication number Publication date
RO77728A (ro) 1981-11-24
BE877394A (fr) 1980-01-02
EP0007204B1 (en) 1982-11-24
GB2028802A (en) 1980-03-12
CH643529A5 (fr) 1984-06-15
GB2101582B (en) 1983-06-08
AT367025B (de) 1982-05-25
ES490214A0 (es) 1981-04-16
GB2028802B (en) 1983-03-30
JPS559097A (en) 1980-01-22
IL57671A0 (en) 1979-10-31
IL57672A0 (en) 1979-10-31
GB2101582A (en) 1983-01-19
RO83051B (ro) 1984-02-28
ES490215A0 (es) 1981-04-16
DK160936B (da) 1991-05-06
ES8104189A1 (es) 1981-04-16
CS209815B2 (en) 1981-12-31
DK160936C (da) 1991-10-21
IE791228L (en) 1980-01-03
FI792081A7 (fi) 1981-01-01
ATA463579A (de) 1983-04-15
DD144761A5 (de) 1980-11-05
FR2430411A1 (fr) 1980-02-01
AU4848779A (en) 1980-01-10
BG31645A3 (bg) 1982-02-15
PH15275A (en) 1982-11-02
GB2028799B (en) 1982-09-08
BG31375A3 (bg) 1981-12-15
RO83051A (ro) 1984-02-21
DE2964604D1 (en) 1983-03-03
FR2450806A1 (fr) 1980-10-03
CS208664B2 (en) 1981-09-15
PL117997B1 (en) 1981-09-30
PT69839A (en) 1979-07-01
EP0006766A1 (en) 1980-01-09
LU81457A1 (fr) 1979-10-30
HU179172B (en) 1982-08-28
RO83052B (ro) 1984-02-28
EP0006766B1 (en) 1983-01-26
FR2450806B1 (fr) 1985-07-12
AT372937B (de) 1983-11-25
CH642618A5 (fr) 1984-04-30
BG31647A3 (bg) 1982-02-15
EP0048037A1 (en) 1982-03-24
BG31646A3 (bg) 1982-02-15
CS208662B2 (en) 1981-09-15
RO83052A (ro) 1984-02-21
KR880002310B1 (ko) 1988-10-22
PT69843A (en) 1979-07-01
SU957761A3 (ru) 1982-09-07
AU4848979A (en) 1980-01-10
SU1007554A3 (ru) 1983-03-23
EG14238A (en) 1983-12-31
RO77732A (ro) 1981-11-24
FI792082A7 (fi) 1981-01-01
DD144762A5 (de) 1980-11-05
AU523721B2 (en) 1982-08-12
JPS6254095B2 (es) 1987-11-13
PL117996B1 (en) 1981-09-30
CA1145767A (en) 1983-05-03
SU849997A3 (ru) 1981-07-23
EP0007204A1 (en) 1980-01-23
AR227165A1 (es) 1982-09-30
KR830001187A (ko) 1983-04-29
LU81458A1 (fr) 1979-10-30
FR2430410A1 (fr) 1980-02-01
GR72940B (es) 1984-01-16
PH14522A (en) 1981-08-26
ATA463679A (de) 1981-10-15
ES482156A1 (es) 1980-08-16
FR2430410B1 (fr) 1986-03-21
CS208663B2 (en) 1981-09-15
PL117551B1 (en) 1981-08-31
ZA793297B (en) 1981-02-25
AR225744A1 (es) 1982-04-30
CA1142954A (en) 1983-03-15
ES8104190A1 (es) 1981-04-16
GB2028799A (en) 1980-03-12
IL57672A (en) 1983-03-31
ZA793296B (en) 1981-02-25
DK268779A (da) 1980-01-04
HU179171B (en) 1982-08-28
BE877393A (fr) 1980-01-02
AR231434A1 (es) 1984-11-30
PL216811A1 (es) 1980-08-25
IE48586B1 (en) 1985-03-20
FR2430411B1 (es) 1983-08-19
DE2964091D1 (en) 1982-12-30
JPS559096A (en) 1980-01-22
SU965350A3 (ru) 1982-10-07
AU523720B2 (en) 1982-08-12
PL121297B1 (en) 1982-04-30
IL57671A (en) 1982-11-30
IE48769B1 (en) 1985-05-15
GR74524B (es) 1984-06-29
PL216814A1 (es) 1980-03-24
AR229080A1 (es) 1983-06-15
NZ190861A (en) 1981-12-15
NZ190863A (en) 1982-05-25
IE791227L (en) 1980-01-03
DK268679A (da) 1980-01-04

Similar Documents

Publication Publication Date Title
ES482155A1 (es) Un procedimiento para la preparacion de derivados de feneta-nolamina.
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES246232Y (es) Aplicador utilizable para el masaje del revestimiento cuta- neo
ES2054716T3 (es) Bis-naftalimidas, su obtencion y empleo.
MX7012A (es) Procedimiento para preparar derivados de acido-cis,endo-2-azabiciclo-(5.3.0.)-decan-3-carboxilico.
ES2194935T3 (es) Preparados estables de transglutaminasa y procedimiento para su preparacion.
AR227637A1 (es) Procedimiento para la preparacion de derivados de n-(fenoxialquil)imidazoles
ES2038270T3 (es) Preparaciones topicas sebosupresoras.
ES8800678A1 (es) Un procedimiento para la preparacion de nuevos benzotiofenos
IT1046291B (it) Procedimento per la preparazione di pelli purificate pronte per la concia di pelli animali
AR230431A1 (es) Compuesto de difenileter 3-hidrazin-4-nitro sustituidos y derivados 3-maleinimido,fenilmaleinimido y dihidroisoindolina,procedimiento para su preparacion y herbicidas que los contienen
IT1065722B (it) Carbammati procedimento per la loro preparazione e loro impiego come agenti disinfestanti e come regolatori della crescita delle piante
ES8100859A1 (es) Un procedimiento para preparar una dispersion espesada acuo-sa y acida, para emplear, bien sea directamente como tal, o-como una base para un producto alimenticio.
ES2061828T3 (es) Composiciones antiirritantes y desensibilizadoras y metodos para su uso.
DK216280A (da) Geometriske isomere af 4,4-dimethyl-1-phenyl-2-(1,2,4-triazol-yl)-1-pentan-3-oler og fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
AR227935A1 (es) Nuevos derivados de(3-amino-4-nitro)fenil-beta,gamma-dihidroxipropil eter usados en el tenido de fibras queratinicas,procedimiento para su preparacion y composicion que los contiene
AR220335A1 (es) Procedimiento para la preparacion de 4(2-hidroxi-3-(amino)-propoxi)-2-benzimidazolinonas y-tionas y compuestos para su exclusivo uso como intermediarios en dicho procedimiento
ES544664A0 (es) Procedimiento para el diagnostico in vitro del sexo
ES544131A0 (es) Procedimiento de obtencion de composiciones para prolongar la accion de herbicidas conteniendo tiolcarbamatos como in- gredientes activos
ES8406877A1 (es) Procedimiento de fabricacion de preparaciones cosmeticas extemporaneas.
AR229875A1 (es) Procedimiento para la preparacion de derivados de 4-sulfanoil fenil-3-sustituido-2-fenilimino-4-tiazolina,intermediarios para su uso exclusivo en el procedimiento y procedimiento para obtener preparados farmaceuticos
ES478414A1 (es) Un procedimiento para la preparacion de n-aril-1,3-oxazoli- din-2,4-dionas.
AR225286A1 (es) Nuevas composiciones cosmeticas para combatir el estado grasoso del cabello y de la piel;compuestos de n-(mercapto-2-etil)-beta-hidroxietilamina de aplicacion exclusiva en dichas composiciones y procedimiento para prepararlas
IT7968144A0 (it) Derivati otticamente attivi della ossazafosforina e procedimento per la loro preparazione
ES2059633T3 (es) 2-terc.-butil-4-cloro-5-(4-terc.-butilbenciltio)-3(2h)-piridazinona para la lucha contra los moluscos.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010201